SINOPHARM-CICC
Sinopharm-CICC is a private equity fund focused on investments in the healthcare industry under CICC Capital.
SINOPHARM-CICC
Status:
Active
Similar Organizations
C-Bridge Capital
Cambridge Capital is a private equity fund focused on investing in the health care industry.
StarCom Group
StarCom Group is a private equity group focused on investments in the consumer sector and high-tech companies.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-18 | Zhenge Biotech | Sinopharm-CICC investment in Series C - Zhenge Biotech | 100 M CNY |
| 2022-08-02 | Xingmai Technology | Sinopharm-CICC investment in Venture Round - Xingmai Technology | 100 M CNY |
| 2020-10-06 | Hinova Pharma | Sinopharm-CICC investment in Series C - Hinova Pharma | 1000 M CNY |
| 2020-08-05 | MicuRx Pharmaceuticals | Sinopharm-CICC investment in Series D - MicuRx Pharmaceuticals | 300 M CNY |
More informations about "Sinopharm-CICC"
Sinopharm CICC investment portfolio | PitchBook
Sinopharm CICC's latest investment was on 10-Apr-2024 in Medi Cover (Beijing), a company within the Consulting Services (B2B) industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting …See details»
Sinopharm-CICC - Investments, Portfolio & Company Exits
Sinopharm-CICC 's most notable exits include MicuRx Pharmaceuticals and Hinova Pharma. Which industries has this organization had the most exits in? Show . MicuRx Pharmaceuticals …See details»
Sinopharm CICC - CB Insights
Mar 30, 2023 Sinopharm CICC is a joint venture fund management company established by Sinopharm Capital and Sinopharm Holdings in 2016. The Sinopharm Zhongjin Medical …See details»
Sinopharm and CICC held a ceremony to sign a …
Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing Postcode: 100191 Tel: 86-10-82287727 Fax: 86-10-62033332. About Us. Profile; Structure; Leadership; Media Center. Top News; ... Sinopharm and CICC held …See details»
Sinopharm CICC Medical Industry Venture Fund I - PitchBook
Jun 14, 2018 Sinopharm CICC Medical Industry Venture Fund I is a 2018 vintage venture capital fund managed by Sinopharm CICC. The fund is located in Shanghai and will invest in China. …See details»
Sinopharm-CICC - Updates, News, Events, Signals & Triggers
Jun 7, 2024 Sinopharm-CICC invests in seed to late-stage companies in the medical, pharmaceutical, and medical device industries, focusing on healthcare and biotechnology …See details»
Sinopharm (company) - Wikipedia
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.The corporation was the indirect major …See details»
Sinopharm-CICC - BioCentury Company Profiles - BCIQ
Sinopharm-CICC - BioCentury Company Profiles for the biopharma industrySee details»
Sinopharm: Chinese Covid vaccine gets WHO …
May 7, 2021 The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine developed by a non-Western country to ...See details»
Gavi signs agreements with Sinopharm and Sinovac for …
Jul 12, 2021 The Sinopharm APA enables Q3 supply, with Gavi committing to purchase, on behalf of the COVAX Facility, 60 million doses that will be made available from July through October 2021. In addition, Gavi has the option to …See details»
WHO approves Sinopharm vaccine in potential boost to COVAX …
May 7, 2021 The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China's state-owned drugmaker Sinopharm on Friday, bolstering Beijing's push …See details»
Chinese drugmakers agree to supply more than half a billion …
Jul 12, 2021 The new deals include up to 170 million doses of the Sinopharm shot and up to 380 million shots of the Sinovac vaccine, to be provided through to the middle of 2022, the …See details»
Sinopharm Vaccine Gets WHO Backing, Facilitating Broader Use
May 7, 2021 China’s Sinopharm Group Co. won World Health Organization backing for its Covid-19 vaccine, paving the way for a wider rollout of the shot in countries scrambling for …See details»
WHO panel approves emergency use of China's Sinopharm vaccine
May 7, 2021 The World Health Organization gave emergency use authorization Friday to a COVID-19 vaccine manufactured by China's Sinopharm, potentially paving the way for millions …See details»
How the Sinopharm Covid-19 Vaccine Works - The New York Times
Dec 30, 2020 May 7 The World Health Organization estimates that the Sinopharm vaccine has an efficacy of 78.1 percent, and authorizes the vaccine for emergency use. July Sinopharm …See details»
WHO chief authorizes emergency use of Sinopharm COVID-19 …
May 7, 2021 GENEVA — The World Health Organization on Friday gave its authorization for emergency use of a COVID-19 vaccine manufactured by China’s Sinopharm, potentially …See details»
WHO approves China's Sinopharm vaccine for emergency use
May 8, 2021 The Sinopharm vaccine joins a list of WHO approved vaccines, in addition to those made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. "The addition of this vaccine …See details»
The Sinopharm COVID-19 vaccine: What you need to know
Jun 10, 2022 The available data on the COVID-19 vaccine Sinopharm in pregnant women are insufficient to assess either vaccine efficacy or vaccine-associated risks in pregnancy. …See details»